Ashley Gallagher, Associate Editor from Pharmacy Times - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment		Pharmacists Play Key Role in Flu Vaccination Efforts - 12 days ago Pegfilgrastim-Fpgk Shows Structural, Functional Biosimilarity to Reference Product - 12 days ago Results of ELEVATUM Show Improvement in Diabetic Macular Edema With Vabysmo for Racial, Ethnic Minority Patients - 13 days ago Report: 82.3% of Reported Vaccine Errors Reached the Patient - 13 days ago Survey: 50% of Active Drug Shortages in the United States Persist for 2 or More Years - 16 days ago Simultaneous Zoster, Inactive Quadrivalent Influenza Vaccination Shows Acceptable Safety for Older Adults - 17 days ago FDA Accepts Biologic License Application for Biosimilar Denosumab - 18 days ago Survey: 8 in 10 Patients Believe Immunization Protects Them From Public Health Threats - 20 days ago Vaccination Rates Increase With Electronic Letter Reminder for Influenza Immunization - 20 days ago Some Disease Burden of Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions - 20 days ago FDA Approves Oral Sulopenem Etzadroxil and Probenecid for Uncomplicated Urinary Tract Infections - 23 days ago Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide - 23 days ago ACIP Lowers Pneumococcal Vaccination Recommendation to Age 50 - 24 days ago FDA Adds Intravenous Fluids to List of Drug Shortages - about 1 month ago FDA Grants Orphan Drug Designation to PPL-002 for the Treatment of Danon Disease - about 2 months ago FDA Approves Ocrevus Zunovo for 2 Forms of Multiple Sclerosis - 2 months ago Remote Interventions From Pharmacists Shown to Improve Blood Glucose Control for Type 2 Diabetes - 2 months ago Expert Discusses Immunotherapy, Antibody Drug Conjugates for Lung Cancer - 2 months ago FDA Authorizes OTC Hearing Aid Software Compatible With Apple AirPods - 2 months ago Non-Medical Switch to Infliximab Biosimilar Demonstrates Similar Outcomes for IBD - 2 months ago FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 2 months ago Exploratory Analysis Shows Favorable Outcomes for Amivantamab-Lazertinib Treatment in NSCLC - 2 months ago Local Therapy Developments Hold Promise for Survival Improvements for NSCLC - 2 months ago FDA Grants Orphan Drug Designation to AISA-021 for Systemic Sclerosis - 2 months ago FDA Accepts Resubmitted NDA for AXS-07 for Acute Treatment of Migraine - 2 months ago Biosimilar of Xolair shows Similarity in Reducing Asthma Exacerbations - 2 months ago Digital Therapeutics in Diabetes Show Potential for Improved Disease Management - 3 months ago FDA Grants Orphan Drug Designation to RAG-18 for Duchenne, Becker Muscular Dystrophy - 3 months ago SELECT Trial Shows Similar Cardiac Benefits of Semaglutide for Heart Failure - 3 months ago Condition Watch, August 2024: Dermatology - 3 months ago Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 3 months ago Study: Biosimilar Etanercept Shows Equivalence With Reference Product for Rheumatoid Arthritis - 3 months ago FDA Accepts NDA and Priority Review Application for Vimseltinib in Tenosynovial Giant Cell Tumors - 3 months ago FDA Grants Orphan Drug, Fast Track Designation to RLS-0071 for aGVHD - 3 months ago FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - 3 months ago FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma - 3 months ago Five Quick Facts to Know About Biosimilars - 3 months ago FDA Grants 510(k) Clearance for Traumagel to Control Bleeding - 3 months ago CMS Announces Negotiated Prices for 10 Drugs Under Inflation Reduction Act - 3 months ago FDA Approves Palopegteriparatide for Treatment of Hypoparathyroidism - 3 months ago New Finding for Diabetic Wounds Has Potential for Use in Developing New Therapeutics - 3 months ago Study: Sales Price of Originator Declines After Introduction of Biosimilars - 3 months ago FDA Declines to Approve MDMA for PTSD - 3 months ago FDA Approves First Nasal Spray for Anaphylaxis - 3 months ago FDA Extends Approval of Fibryga to Include Bleeding Patients With Acquired Fibrinogen Deficiency - 4 months ago FDA Grants Priority Review for Asciminib for Chronic Myeloid Leukemia - 4 months ago FDA Grants Breakthrough Device Designation for System Maintaining Weight Loss After GLP-1 - 4 months ago FDA Grants Orphan Drug Designation to ZMA001 for Pulmonary Arterial Hypertension - 4 months ago FDA Accepts New Drug Application for Suzetrigine to Manage Acute Pain - 4 months ago FDA Approves Cerliponase Alfa for Expanded Indication of CLN2 Disease - 4 months ago